The total return over the past 12 months is +142.89% vs. +16.94% for the S&P 500. So far it's up +20.61% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +142.89% | +49.25% | (5.51%) | N/A | N/A | N/A |
| Total Return CAGR | +142.89% | +49.25% | (5.51%) | N/A | N/A | N/A |
| Revenue CAGR | (58.40%) | (15.50%) | +9.96% | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Nurix Therapeutics, Inc. (NRIX)
| Year | Start price | End price | NRIX Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $18.97 | $22.88 | +20.61% | +14.51% | +6.10% |
| 2025 | $18.84 | $18.97 | +0.69% | +17.72% | (17.03%) |
| 2024 | $10.32 | $18.84 | +82.56% | +24.89% | +57.67% |
| 2023 | $10.98 | $10.32 | (6.01%) | +26.19% | (32.20%) |
| 2022 | $28.95 | $10.98 | (62.07%) | (18.17%) | (43.90%) |
| 2021 | $32.88 | $28.95 | (11.95%) | +28.74% | (40.69%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
